Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/20/20242:00AMGlobeNewswire Inc.AMG Critical Materials Acquires a Strategic Stake in Savannah ResourcesTG:ADGAMG Critical Materials NV
06/20/20242:00AMBusiness WireYellowstone Biosciences launches with £16.5 million to pioneer soluble bispecific TCR-based therapies for cancer
06/20/20242:00AMGlobeNewswire Inc.TGS and PGS - key dates for completion of mergerTG:PGS1PGS ASA
06/20/20242:00AMGlobeNewswire Inc.AMG Critical Materials Acquires a Strategic Stake in Savannah ResourcesNYSE:AMGAffiliated Managers Group Inc
06/20/20241:56AMAlliance NewsAlliance NewsIN BRIEF: Sanderson Design pays GBP2.3 million to remove pension riskLSE:SDGSanderson Design Group Plc
06/20/20241:53AMGlobeNewswire Inc.freebeat and Boston Celtics: The Collaborative Power Behind Championship Victory
06/20/20241:51AMGlobeNewswire Inc.Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and NutritionTG:BSNDanone
06/20/20241:51AMGlobeNewswire Inc.Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and NutritionEU:BNDanone
06/20/20241:51AMGlobeNewswire Inc.Danone ouvre le nouveau chapitre de sa stratégie Renew; Projetant l’entreprise dans le futur de la santé et de la nutritionTG:BSNDanone
06/20/20241:51AMGlobeNewswire Inc.Danone ouvre le nouveau chapitre de sa stratégie Renew; Projetant l’entreprise dans le futur de la santé et de la nutritionBIT:DNNDanone
06/20/20241:51AMGlobeNewswire Inc.Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and NutritionBIT:DNNDanone
06/20/20241:51AMGlobeNewswire Inc.Danone ouvre le nouveau chapitre de sa stratégie Renew; Projetant l’entreprise dans le futur de la santé et de la nutritionEU:BNDanone
06/20/20241:51AMPR Newswire (US)Envision Energy Launches Advanced 5 MWh Container Battery Energy Storage System with Industry-Leading Safety Standards
06/20/20241:43AMPR Newswire (US)More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market
06/20/20241:41AMAlliance NewsAlliance NewsJapan "seriously concerned" over Putin's North Korea treaty
06/20/20241:38AMAlliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 called higher before BoE decision
06/20/20241:33AMAlliance NewsAlliance NewsGET READY: CMC Markets, Cordiant, DS Smith, XPS Pensions at 0700 BST
06/20/20241:33AMGlobeNewswire Inc.Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order
06/20/20241:33AMGlobeNewswire Inc.Vallourec prolonge son contrat avec la compagnie pétrolière nationale d'Abu Dhabi et remporte une nouvelle commande
06/20/20241:33AMGlobeNewswire Inc.Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new orderEU:VKVallourec
06/20/20241:33AMPR Newswire (US)Envision Energy Launches Advanced 5 MWh Container Battery Energy Storage System with Industry-Leading Safety Standards
06/20/20241:32AMPR Newswire (Canada)More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market
06/20/20241:32AMPR Newswire (US)More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market
06/20/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
06/20/20241:30AMGlobeNewswire Inc.Sampo plc’s share buybacks 19 June 2024
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)TG:6OPOSE Immunotherapeutics
06/20/20241:30AMBusiness WireSensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable TechnologiesEU:ALSENSensorion
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)LSE:0RADOse Immunotherapeutics Sa
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)EU:OSEOSE Immunotherapeutics
06/20/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited